SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union
April 27, 2025 10:35 ET | Source: SpringWorks Therapeutics, Inc. STAMFORD, Conn.,…
Tag: chmp